Deepak Sabharwal and Iana Malasevskaia, “Role of PCSK9 Inhibitors in Contemporary Lipid-Lowering Era: A Systematic Review of LDL-C Reduction, Cardiovascular Outcomes, and Use in Statin-Intolerant and Very-High-Risk Patients”, Journal For International Medical Graduates, vol. 5, no. 1, Apr. 2026, doi: 10.56570/hkdzy418.